Filter News
Area of Research
- (-) Clean Energy (8)
- (-) Nuclear Science and Technology (3)
- Advanced Manufacturing (1)
- Computational Engineering (1)
- Computer Science (2)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (1)
- Fusion Energy (1)
- Isotopes (1)
- Materials (5)
- National Security (2)
- Neutron Science (3)
- Quantum information Science (1)
- Supercomputing (16)
News Topics
- (-) Biomedical (1)
- (-) Computer Science (3)
- (-) Grid (2)
- (-) Nuclear Energy (2)
- (-) Transportation (5)
- 3-D Printing/Advanced Manufacturing (12)
- Advanced Reactors (1)
- Artificial Intelligence (1)
- Big Data (1)
- Bioenergy (6)
- Biology (2)
- Buildings (3)
- Chemical Sciences (1)
- Clean Water (1)
- Climate Change (1)
- Composites (3)
- Coronavirus (1)
- Critical Materials (1)
- Cybersecurity (1)
- Decarbonization (1)
- Energy Storage (8)
- Environment (5)
- High-Performance Computing (1)
- Isotopes (1)
- Machine Learning (1)
- Materials (5)
- Materials Science (4)
- Microscopy (1)
- Nanotechnology (1)
- Neutron Science (2)
- Polymers (2)
- Security (2)
- Summit (1)
- Sustainable Energy (10)
Media Contacts
![Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227. Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227.](/sites/default/files/styles/list_page_thumbnail/public/2016-P07827%5B1%5D.jpg?itok=yJbnFQLU)
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.